| Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer (NCT01620593) | The University of Texas Health Science Center at San Antonio | 2011-04-01 |
| MRI in Diagnosing Prostate Cancer (NCT01292291) | University College London Hospitals | 2011-04-01 |
| PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer (NCT00898326) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2011-04-01 |
| DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study (NCT01417676) | University of Aarhus | 2011-04-01 |
| Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer (NCT04239599) | Sunnybrook Health Sciences Centre | 2011-03-31 |
| Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies (NCT01254864) | M.D. Anderson Cancer Center | 2011-03-16 |
| A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy (NCT01279785) | Molecular Insight Pharmaceuticals, Inc. | 2011-03-01 |
| Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal Cancers (NCT01325961) | Institut Cancerologie de l'Ouest | 2011-03-01 |
| A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer (NCT01234311) | Active Biotech AB | 2011-03-01 |
| BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) (NCT01520441) | The University of Texas Health Science Center, Houston | 2011-03-01 |
| Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer (NCT01558492) | Weill Medical College of Cornell University | 2011-03-01 |
| 3D Recording of a Trans-rectal Prostate Biopsy (NCT01314456) | HaEmek Medical Center, Israel | 2011-03-01 |
| Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer (NCT01087580) | Northwestern University | 2011-03-01 |
| Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer (NCT01917890) | Shahid Beheshti University of Medical Sciences | 2011-03-01 |
| Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer (NCT01317641) | Orion Corporation, Orion Pharma | 2011-03-01 |
| Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists (NCT01366053) | CMX Research | 2011-03-01 |
| T-cell-immunity During Standard Radiotherapy in Localised Prostate Cancer (NCT01376674) | University Hospital Tuebingen | 2011-03-01 |
| Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer (NCT01326286) | Vanderbilt University | 2011-03-01 |
| A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01283373) | Genentech, Inc. | 2011-03-01 |
| Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors (NCT01231932) | National Institute of Nursing Research (NINR) | 2011-02-04 |
| Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer (NCT01296243) | Genta Incorporated | 2011-02-01 |
| 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer (NCT01296672) | The University of Texas Health Science Center at San Antonio | 2011-02-01 |
| Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia (NCT01320735) | AbbVie (prior sponsor, Abbott) | 2011-02-01 |
| Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care (NCT01346839) | Baylor College of Medicine | 2011-02-01 |
| Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer (NCT01300104) | Danish Cancer Society | 2011-02-01 |
| Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. (NCT01310894) | Steba Biotech S.A. | 2011-02-01 |
| Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer (NCT01296139) | National Cancer Institute (NCI) | 2011-01-26 |
| Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery (NCT01272050) | Swiss Cancer Institute | 2011-01-06 |
| Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors (NCT01286987) | Pfizer | 2011-01-03 |
| Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer (NCT01324583) | Sanofi | 2011-01-01 |
| MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease (NCT01522118) | University of Roma La Sapienza | 2011-01-01 |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) (NCT02564120) | UNC Lineberger Comprehensive Cancer Center | 2011-01-01 |
| Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance (NCT01238172) | Alliance for Clinical Trials in Oncology | 2011-01-01 |
| Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) (NCT01006395) | Austin Health | 2011-01-01 |
| Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer (NCT01511874) | HanAll BioPharma Co., Ltd. | 2011-01-01 |
| Hypofractionated Stereotactic Body Radiation Therapy (SBRT) (NCT01288534) | University of Michigan Rogel Cancer Center | 2011-01-01 |
| Does Protein Restriction Inhibit Prostrate Cancer Growth (NCT01692587) | Washington University School of Medicine | 2011-01-01 |
| Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique? (NCT02761135) | Kronoberg County Council | 2011-01-01 |
| Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer (NCT01574846) | Orion Corporation, Orion Pharma | 2011-01-01 |
| Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program (NCT01275404) | Memorial Sloan Kettering Cancer Center | 2010-12-28 |
| Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer (NCT01243385) | Swiss Cancer Institute | 2010-12-23 |
| Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer (NCT01342367) | University of Chicago | 2010-12-17 |
| Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients (NCT01254513) | UNICANCER | 2010-12-09 |
| Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2 (NCT01244568) | University of North Carolina, Chapel Hill | 2010-12-01 |
| A Study of Degarelix in Taiwanese Patients With Prostate Cancer (NCT01220869) | Ferring Pharmaceuticals | 2010-12-01 |
| Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome (NCT01826617) | St. Luke's Medical Center, Philippines | 2010-12-01 |
| Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer (NCT01065441) | Michael Har-Noy | 2010-12-01 |
| Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole (NCT01275651) | Alliance for Clinical Trials in Oncology | 2010-12-01 |
| Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg (NCT01257425) | Ipsen | 2010-12-01 |
| Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca (NCT01289067) | William K. Oh | 2010-12-01 |
| CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse (NCT01248741) | British Columbia Cancer Agency | 2010-12-01 |
| Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer. (NCT01193257) | Millennium Pharmaceuticals, Inc. | 2010-11-15 |
| Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01240629) | University of Southern California | 2010-11-02 |
| Redes III Patient Navigator Qol Study (NCT02275754) | The University of Texas Health Science Center at San Antonio | 2010-11-01 |
| Hyaluronic Acid for Hypofractionated Prostate Radiotherapy (NCT02165020) | Hospices Civils de Lyon | 2010-11-01 |
| Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer (NCT01188187) | Achieve Life Sciences | 2010-11-01 |
| Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate Cancer (NCT01764347) | University of Southern California | 2010-11-01 |
| The Effects of Epidural Anesthesia on the Bioavailability of Nitric Oxide and Renal Function in Patients Undergoing Laparoscopic Surgery (NCT01325844) | Yonsei University | 2010-11-01 |
| International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer (NCT01252693) | Spectrum Pharmaceuticals, Inc | 2010-11-01 |
| Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 (NCT01132404) | Millennium Pharmaceuticals, Inc. | 2010-11-01 |
| Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer (NCT01277562) | City of Hope Medical Center | 2010-11-01 |
| Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer (NCT01230866) | Proton Collaborative Group | 2010-11-01 |
| Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer (NCT01303705) | Providence Health & Services | 2010-10-14 |
| Hypofractionated SBRT For Prostate Cancer (NCT00977860) | Adam Olson | 2010-10-07 |
| L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors (NCT01105130) | Wake Forest University Health Sciences | 2010-10-01 |
| A Study of Olaratumab (IMC-3G3) in Prostate Cancer (NCT01204710) | Eli Lilly and Company | 2010-10-01 |
| Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer (NCT01229618) | University of California, San Francisco | 2010-10-01 |
| Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer (NCT01193244) | Millennium Pharmaceuticals, Inc. | 2010-10-01 |
| A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer (NCT01215526) | Ferring Pharmaceuticals | 2010-10-01 |
| Abiraterone Post Ketoconazole for Prostate Cancer (NCT01199146) | University of California, San Francisco | 2010-09-10 |
| Neoadjuvant Ipilimumab in Prostate Cancer (NCT01194271) | M.D. Anderson Cancer Center | 2010-09-01 |
| Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy (NCT01450683) | Stanford University | 2010-09-01 |
| Digoxin for Recurrent Prostate Cancer (NCT01162135) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2010-09-01 |
| Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate (NCT01174017) | British Columbia Cancer Agency | 2010-09-01 |
| Metformin in Castration-Resistant Prostate Cancer (NCT01215032) | Massachusetts General Hospital | 2010-09-01 |
| Effectiveness of Open and Robotic Prostatectomy (NCT01325506) | Beth Israel Deaconess Medical Center | 2010-09-01 |
| Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer (NCT01417182) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2010-09-01 |
| Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer (NCT01226888) | Massachusetts General Hospital | 2010-09-01 |
| PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer (NCT01205646) | Barbara Ann Karmanos Cancer Institute | 2010-09-01 |
| Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy (NCT01367418) | Örebro University, Sweden | 2010-09-01 |
| Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis (NCT01350180) | Dr. Tamim Niazi | 2010-09-01 |
| Study of Treatment Choice in Patients With Localized Prostate Cancer (NCT01177865) | University College London Hospitals | 2010-09-01 |
| Open Label Prostate Cancer Study (NCT01162395) | AstraZeneca | 2010-08-01 |
| Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men (NCT01937585) | Fox Chase Cancer Center | 2010-08-01 |
| SBRT for Organ Confined Prostate Cancer (NCT02653248) | Northwell Health | 2010-08-01 |
| Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer (NCT02516995) | Gustave Roussy, Cancer Campus, Grand Paris | 2010-08-01 |
| Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance (NCT01191099) | University of Zurich | 2010-08-01 |
| Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate Cancers (NCT01148069) | Rennes University Hospital | 2010-07-30 |
| Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC) (NCT01171898) | Aragon Pharmaceuticals, Inc. | 2010-07-26 |
| Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men (NCT00581672) | Memorial Sloan Kettering Cancer Center | 2010-07-25 |
| The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer Diagnosis (NCT01176526) | National Human Genome Research Institute (NHGRI) | 2010-07-19 |
| QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA (NCT01147965) | NantCell, Inc. | 2010-07-16 |
| GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer (NCT01176513) | GE Healthcare | 2010-07-01 |
| Effects of Sulforaphane on Normal Prostate Tissue (NCT00946309) | Fred Hutchinson Cancer Center | 2010-07-01 |
| BR55 in Prostate Cancer: an Exploratory Clinical Trial (NCT01253213) | Bracco Diagnostics, Inc | 2010-07-01 |
| Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer (NCT01057810) | Bristol-Myers Squibb | 2010-07-01 |
| High Risk Prostate Cancer Prevention Study (NCT01174953) | University of Kansas | 2010-07-01 |
| Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer (NCT01084655) | Millennium Pharmaceuticals, Inc. | 2010-07-01 |
| Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration (NCT01161563) | Watson Pharmaceuticals | 2010-07-01 |
| Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer (NCT01163448) | Memorial Sloan Kettering Cancer Center | 2010-07-01 |